Business
Perimeter Medical Imaging AI to Present at the Virtual Gravitas Healthcare Investor Day
TORONTO, ON / ACCESSWIRE / September 29, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PIN...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging AI to Present at the Virtual Gravitas Healthcare Investor DayTORONTO, ON / ACCESSWIRE / September 29, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter's President and CFO will present a company overview at the Gravitas Healthcare Investor Day on Thursday, October 1, 2020 at 12:00 p.m. ET.The live presentation will be webcast and may be accessed on Perimeter's website under the \"Investors\" section at https://ir.perimetermed.com/.This year's Gravitas Healthcare Investor Day will feature several leaders in healthcare and will be attended virtually by institutional and retail investors from North America and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.comConference Details:Event: Gravitas Healthcare Investor Day (virtual)Date: Thursday, October 1, 2020Time: 9:00 a.m. to 5:30 p.m. ETRegistration: Register by clicking hereAbout Perimeter Medical Imaging AI, Inc. Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is a point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter's OTIS™ platform is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing ad...